CCRL2 was shown to regulate inflammatory reactions in diverse pathological conditions, including hypersensitivity reactions, arthritis, and experimental autoimmune encephalitis [21,36,37,41], but its role in cancer has been investigated in few studies so far. Here, CCRL2 is linked to arthritic joint disease.